UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data

Substance abuse treatment, prevention and policy, 2021-11, Vol.16 (1), p.87-14, Article 87

2021

Volltextzugriff (PDF)

Client experiences using a new supervised consumption service in Sudbury, Ontario: A qualitative study

PloS one, 2023-10, Vol.18 (10), p.e0292862-e0292862

2023

Volltextzugriff (PDF)

Assessing service and treatment needs and barriers of youth who use illicit and non-medical prescription drugs in Northern Ontario, Canada

PloS one, 2019-12, Vol.14 (12), p.e0225548

2019

Volltextzugriff (PDF)

A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada

BMC public health, 2021-11, Vol.21 (1), p.2021-2021, Article 2021

2021

Volltextzugriff (PDF)

The decriminalization of illicit drugs in British Columbia: a national evaluation protocol

BMC public health, 2024-10, Vol.24 (1), p.2879-17, Article 2879

2024

Volltextzugriff (PDF)

Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review

BMC public health, 2021-03, Vol.21 (1), p.597-16, Article 597

2021

Volltextzugriff (PDF)

Connections between unemployment insurance, poverty and health: a systematic review

European journal of public health, 2018-04, Vol.28 (2), p.269-275

2018

Volltextzugriff (PDF)

Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?

Harm reduction journal, 2022-08, Vol.19 (1), p.1-89, Article 89

2022

Volltextzugriff (PDF)

An environmental scan of residential treatment service provision in Ontario

Substance abuse treatment, prevention and policy, 2023-12, Vol.18 (1), p.73-73, Article 73

2023

Volltextzugriff (PDF)

"2.5 g, I could do that before noon": a qualitative study on people who use drugs' perspectives on the impacts of British Columbia's decriminalization of illegal drugs threshold limit

Substance abuse treatment, prevention and policy, 2023-06, Vol.18 (1), p.32-12, Article 32

2023

Volltextzugriff (PDF)

Unpacking the Effects of Decriminalization: Understanding Drug Use Experiences and Risks among Individuals Who Use Drugs in British Columbia

Harm reduction journal, 2024-10, Vol.21 (1), p.190-13, Article 190

2024

Volltextzugriff (PDF)

Effects of cannabis legalisation on patterns of cannabis consumption among adolescents in Ontario, Canada (2001–2019)

Drug and alcohol review, 2024-03, Vol.43 (3), p.764-774

2024

Volltextzugriff (PDF)

Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study

Harm reduction journal, 2023-07, Vol.20 (1), p.99-99, Article 99

2023

Volltextzugriff (PDF)

Trends in drug overdose deaths among adults 65 years of age and older in Canada (2000–2022)

Drug and alcohol dependence reports, 2024-09, Vol.12, p.100254, Article 100254

2024

Volltextzugriff (PDF)

The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review

Addiction science & clinical practice, 2023-08, Vol.18 (1), p.1-48, Article 48

2023

Volltextzugriff (PDF)

Youth substance use service provider's perspectives on use and service access in ontario: time to reframe the discourse

Substance abuse treatment, prevention and policy, 2022-02, Vol.17 (1), p.9-9, Article 9

2022

Volltextzugriff (PDF)

Navigating the nexus between British Columbia's public consumption and decriminalization policies of illegal drugs

Health research policy and systems, 2024-05, Vol.22 (1), p.60-60, Article 60

2024

Volltextzugriff (PDF)

Priority setting for Canadian Take-Home Naloxone best practice guideline development: an adapted online Delphi method

Harm reduction journal, 2022-07, Vol.19 (1), p.71-8, Article 71

2022

Volltextzugriff (PDF)

Changes in medical cannabis use in Ontario, Canada (2014 to 2019): Trajectory of trends, medical authorization patterns and association with recreational cannabis legalization

Preventive medicine reports, 2024-08, Vol.44, p.102805, Article 102805

2024

Volltextzugriff (PDF)

Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada

The International journal of drug policy, 2021-07, Vol.93, p.103237-103237, Article 103237

2021

Volltextzugriff (PDF)

The increase in benzodiazepine-laced drugs and related risks in Canada: The urgent need for effective and sustainable solutions

The International journal of drug policy, 2023-01, Vol.111, p.103933, Article 103933

2023

Volltextzugriff (PDF)

Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001–2019)

Drug and alcohol dependence, 2023-03, Vol.244, p.109765, Article 109765

2023

Volltextzugriff (PDF)

‘Small communities, large oversight’: The impact of recent legislative changes concerning supervised consumption services on small communities in Ontario, Canada

The International journal of drug policy, 2020-08, Vol.82, p.102822-102822, Article 102822

2020

Volltextzugriff (PDF)

Document d’orientation sur la distribution et l’utilisation de trousses de naloxone à emporter par les intervenants et intervenantes communautaires en cas de surdose au Canada

Canadian Medical Association journal (CMAJ), 2023-10, Vol.195 (38), p.E1312-E1325

2023

Volltextzugriff (PDF)

Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review

The International journal of drug policy, 2024-05, Vol.127, p.104343, Article 104343

2024

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(44)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data

Client experiences using a new supervised consumption service in Sudbury, Ontario: A qualitative study

Assessing service and treatment needs and barriers of youth who use illicit and non-medical prescription drugs in Northern Ontario, Canada

A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada

The decriminalization of illicit drugs in British Columbia: a national evaluation protocol

Take-home naloxone programs for suspected opioid overdose in community settings: a scoping umbrella review

Connections between unemployment insurance, poverty and health: a systematic review

Opioid agonist treatment take-home doses (‘carries’): Are current guidelines resulting in low treatment coverage among high-risk populations in Canada and the USA?

An environmental scan of residential treatment service provision in Ontario

"2.5 g, I could do that before noon": a qualitative study on people who use drugs' perspectives on the impacts of British Columbia's decriminalization of illegal drugs threshold limit

Unpacking the Effects of Decriminalization: Understanding Drug Use Experiences and Risks among Individuals Who Use Drugs in British Columbia

Effects of cannabis legalisation on patterns of cannabis consumption among adolescents in Ontario, Canada (2001–2019)

Identifying barriers and facilitators to COVID-19 vaccination uptake among People Who Use Drugs in Canada: a National Qualitative Study

Trends in drug overdose deaths among adults 65 years of age and older in Canada (2000–2022)

The impact of methamphetamine use on medications for opioid use disorder (MOUD) treatment retention: a scoping review

Youth substance use service provider's perspectives on use and service access in ontario: time to reframe the discourse

Navigating the nexus between British Columbia's public consumption and decriminalization policies of illegal drugs

Priority setting for Canadian Take-Home Naloxone best practice guideline development: an adapted online Delphi method

Changes in medical cannabis use in Ontario, Canada (2014 to 2019): Trajectory of trends, medical authorization patterns and association with recreational cannabis legalization

Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada

The increase in benzodiazepine-laced drugs and related risks in Canada: The urgent need for effective and sustainable solutions

Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001–2019)

‘Small communities, large oversight’: The impact of recent legislative changes concerning supervised consumption services on small communities in Ontario, Canada

Document d’orientation sur la distribution et l’utilisation de trousses de naloxone à emporter par les intervenants et intervenantes communautaires en cas de surdose au Canada

Examining inequities in access to opioid agonist treatment (OAT) take-home doses (THD): A Canadian OAT guideline synthesis and systematic review

Suchergebnisse filtern